{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-115900","form_type":"8-K","ticker":"OCGN","cik":"0001372299","company_name":"Ocugen, Inc.","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.279034+00:00","generated_at":"2026-05-30T02:44:42.948558+00:00","sec_items":["1.01","2.03","3.02","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ocugen closes $30M credit facility with Avenue Capital; proceeds for clinical development","bullets":["Term loans of $30M fully funded on Nov 6, 2024; maturity Nov 1, 2028; interest rate prime + 4.25% (floor at closing prime).","Up to $6M of principal convertible into common stock at 80% of trading price; conversion capped at 19.9% of outstanding shares.","Issued 1,056,338 shares to Lenders under Subscription Agreement; registration statement to be filed within 90 days.","Proceeds to support OCU400 Phase 3 liMeliGhT trial and BLA/MAA submissions; cash runway extends into Q1 2026.","Loan secured by all assets; negative pledge on IP; prepayment premiums from 3% down to 0.5% over time."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-115900","json":"https://secwatch.observer/filing/0001104659-24-115900.json","markdown":"https://secwatch.observer/filing/0001104659-24-115900.md","text":"https://secwatch.observer/filing/0001104659-24-115900.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372299/000110465924115900/0001104659-24-115900-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372299/000110465924115900/tm2427800d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:44:42.948558+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}